Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adjunctive Treatment of Major Depressive Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT05850689
What this trial is testing

Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Intra-Cellular Therapies, Inc. 470
Large-scale testing (Phase 3)Study completedNCT02951988
What this trial is testing

Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder

Who this might be right for
Depressive Disorder, Major
Naurex, Inc, an affiliate of Allergan plc 1,304
Large-scale testing (Phase 3)Study completedNCT04985942
What this trial is testing

Clinical Trial of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Intra-Cellular Therapies, Inc. 485
Large-scale testing (Phase 3)Study completedNCT01072630
What this trial is testing

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Who this might be right for
Depression
Cephalon 492
Large-scale testing (Phase 3)Study completedNCT01360632
What this trial is testing

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Who this might be right for
Depressive DisorderDepressionDepressive Disorder, Major+2 more
Otsuka Pharmaceutical Development & Commercialization, Inc. 1,539
Not applicableStudy completedNCT00186498
What this trial is testing

Memantine to Reduce Neurocognitive Deficits Following Unilateral ECT for the Treatment of a Major Depression

Who this might be right for
Depressive Disorder, Major
Stanford University 11
Testing effectiveness (Phase 2)Study completedNCT02805439
What this trial is testing

Efficacy and Safety of S 47445 Versus Placebo as Adjunctive Treatment in Depressed Patients Not Fully Recovered From Depressive Symptoms With a Current Antidepressant Treatment

Who this might be right for
Major Depressive Disorder
Institut de Recherches Internationales Servier 400
Large-scale testing (Phase 3)Study completedNCT02085135
What this trial is testing

Different Titration Schedules of ALKS 5461 in Adults With Major Depressive Disorder (MDD)

Who this might be right for
Major Depressive Disorder
Alkermes, Inc. 66
Large-scale testing (Phase 3)Study completedNCT01403662
What this trial is testing

Evaluating the Efficacy of Adjunctive Minocycline for the Treatment of Bipolar Depression

Who this might be right for
Bipolar DisorderBipolar DepressionBipolar I Depression+1 more
University Health Network, Toronto 29
Large-scale testing (Phase 3)Study completedNCT01838876
What this trial is testing

Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy in Patients With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Forest Laboratories 442
Large-scale testing (Phase 3)Looking for participantsNCT06963021
What this trial is testing

NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Who this might be right for
Major Depressive Disorder
Neurocrine Biosciences 200
Large-scale testing (Phase 3)Ended earlyNCT05518149
What this trial is testing

Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD)

Who this might be right for
Depressive Disorder, Major
Janssen Research & Development, LLC 871
Not applicableStudy completedNCT02176408
What this trial is testing

Efficacy of Adjunctive Exercise for the Behavioral Treatment of Major Depression

Who this might be right for
Major Depressive Disorder
Boston University Charles River Campus 38
Not applicableStudy completedNCT04770285
What this trial is testing

Trial to Evaluate the Effectiveness of a Digital Therapeutics in Adults Diagnosed With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 386
Large-scale testing (Phase 3)Looking for participantsNCT06911112
What this trial is testing

NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Who this might be right for
Major Depressive Disorder
Neurocrine Biosciences 200
Large-scale testing (Phase 3)UnknownNCT03423680
What this trial is testing

Abilify® Tablet(Aripiprazole) as an Adjunctive Treatment in the Bipolar Depression

Who this might be right for
Depression, Bipolar
Korea Otsuka Pharmaceutical Co., Ltd. 390
Testing effectiveness (Phase 2)Study completedNCT00797966
What this trial is testing

Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 850
Large-scale testing (Phase 3)Study completedNCT04513912
What this trial is testing

Seltorexant Compared to Quetiapine XR as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy

Who this might be right for
Depressive Disorder, Major
Janssen Research & Development, LLC 757
Testing effectiveness (Phase 2)Study completedNCT04466345
What this trial is testing

Semaglutide for the Treatment of Cognitive Dysfunction in Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
University Health Network, Toronto 72
Post-approval studies (Phase 4)Study completedNCT04830215
What this trial is testing

Brexpiprazole as Adjunctive Therapy in Adults With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 122
Next Page